Advancing Life Sciences via Genetic Alphabet Expansion
OUR COMPANY
About Us
Xenolis Pte Ltd is a life sciences company that specializes in the discovery and development of XenoAptamers for use in life sciences application and research. XenoAptamers are advanced aptamers that contain proprietary unnatural bases and have unique properties and configurations. This allows us to produce aptamers with high affinity and specificity to their targets, making them ideal for broad applications across life sciences.
Xenolis’ proprietary ExSELEX™ platform is a transformative and agnostic technology that impacts multiple sectors of the life science industry via genetic alphabet expansion. This platform extends its utility from research and discovery, translational research and biopharmaceutical development, and clinical applications.
Our Science
Technology
XenoAptamers
The ExSELEX™ Platform
Six-Letter DNA Alphabet
Genetic Alphabet Expansion Technology
Genetic Alphabet Expansion Technology
Introducing Xenolis, where innovation meets precision. With our proprietary artificial base pairs (Ds−Px and Ds−Pa), we are crafting novel nucleic acids like XenoAptamers and more.
Step into genetic innovation’s future with our cutting-edge genetic alphabet expansion technology! By harnessing artificially created third base pairs (unnatural base pairs), we are transforming traditional 4-letter DNA into groundbreaking 6-letter DNA.